In addition, the administration of a neoantigen peptide vaccine (NeoVAC) combined with α‐PD‐1 can elicit a strong neoantigen‐specific antitumor response and establish long‐term tumor‐specific immune memory in HCC by increasing CD8+ TRM infiltration.274. This evidence concerns the gene CD8A and hepatocellular carcinoma.